20 articles
Expert reviews rank fisetin and quercetin as top senolytics, with spermidine and resveratrol as supporting players in longevity supplement stacks.
A product review breaks down the evidence tiers for four popular longevity supplements and rates the best commercial stacks.
Expert reviews compare leading senolytic and NAD+ supplement brands on ingredients, evidence quality, and value.
Expert reviews compare NMN and NR head-to-head. NMN edges out for muscle and sleep benefits; NR leads for neuroprotection.
New expert reviews compare NMN and NR head-to-head, ranking top products by purity, absorption, and clinical evidence.
A rigorous product review reveals major quality gaps in NAD+ supplements and what dosing evidence actually supports.
A comparative review of NMN and NR supplements weighs tissue targeting, clinical evidence, and top-rated products for NAD+ optimization.
Expert reviews confirm NR and NMN raise blood NAD+, but longevity proof remains elusive and product quality varies widely.
A head-to-head comparison of NMN and NR supplements reveals distinct benefit profiles — and major quality gaps across popular brands.
Expert reviews compare leading NMN and NR supplements on clinical evidence, purity, and value — with key caveats on what the science can and cannot yet prove.
A candid breakdown of top NAD+ booster brands reveals strong biomarker data but slim evidence for real longevity outcomes.
A 2026 comparative review of leading NAD+ supplements reveals NR has stronger human data, while NMN marketing often outpaces clinical proof.
Independent testing exposes widespread quality failures in NAD+ precursor supplements, with actionable guidance on which brands actually deliver.
Independent testing reveals rampant quality failures in NMN, NR, and NAD+ supplements. Know what to look for before buying.
Expert reviews compare NMN and NR on human trial data, bioavailability, and top-ranked brands for 2026.
Both NMN and NR raise NAD+ levels in humans, but clinical proof of anti-aging benefits is still lacking — and product quality varies widely.
A new review identifies PRMT enzymes as master regulators linking mitochondrial stress to sarcopenia and neuromuscular decline.
Biomolecular condensates formed by liquid-liquid phase separation offer a new platform for clearing disease-causing proteins conventional drugs can't target.
A Cochrane review of two RCTs finds very low-certainty evidence that IGF-1 neither prevents nor worsens retinopathy of prematurity in extremely preterm infants.
A Cochrane meta-analysis of 8 RCTs finds most pharmacological treatments fail to improve ataxia scores, though upper limb dexterity may benefit.
